These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22658745)

  • 21. Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice.
    Yu T; Liu C; Belichenko P; Clapcote SJ; Li S; Pao A; Kleschevnikov A; Bechard AR; Asrar S; Chen R; Fan N; Zhou Z; Jia Z; Chen C; Roder JC; Liu B; Baldini A; Mobley WC; Yu YE
    Brain Res; 2010 Dec; 1366():162-71. PubMed ID: 20932954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome.
    Martinez de Lagran M; Elizalde-Torrent A; Paredes R; Clotet B; Dierssen M
    J Cell Mol Med; 2022 Aug; 26(15):4210-4215. PubMed ID: 35762509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.
    Hamlett ED; Boger HA; Ledreux A; Kelley CM; Mufson EJ; Falangola MF; Guilfoyle DN; Nixon RA; Patterson D; Duval N; Granholm AC
    Curr Alzheimer Res; 2016; 13(1):35-52. PubMed ID: 26391050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.
    Belichenko PV; Kleschevnikov AM; Salehi A; Epstein CJ; Mobley WC
    J Comp Neurol; 2007 Oct; 504(4):329-45. PubMed ID: 17663443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human and mouse model cognitive phenotypes in Down syndrome: implications for assessment.
    Edgin JO; Mason GM; Spanò G; Fernández A; Nadel L
    Prog Brain Res; 2012; 197():123-51. PubMed ID: 22541291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome.
    Duchon A; Pothion S; Brault V; Sharp AJ; Tybulewicz VL; Fisher EM; Herault Y
    Behav Brain Res; 2011 Mar; 217(2):271-81. PubMed ID: 21047530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits.
    Zhang L; Meng K; Jiang X; Liu C; Pao A; Belichenko PV; Kleschevnikov AM; Josselyn S; Liang P; Ye P; Mobley WC; Yu YE
    Hum Mol Genet; 2014 Feb; 23(3):578-89. PubMed ID: 24041763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions.
    Yu T; Li Z; Jia Z; Clapcote SJ; Liu C; Li S; Asrar S; Pao A; Chen R; Fan N; Carattini-Rivera S; Bechard AR; Spring S; Henkelman RM; Stoica G; Matsui S; Nowak NJ; Roder JC; Chen C; Bradley A; Yu YE
    Hum Mol Genet; 2010 Jul; 19(14):2780-91. PubMed ID: 20442137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of trisomic proteins in Down syndrome model systems.
    Spellman C; Ahmed MM; Dubach D; Gardiner KJ
    Gene; 2013 Jan; 512(2):219-25. PubMed ID: 23103828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists.
    Kleschevnikov AM; Belichenko PV; Faizi M; Jacobs LF; Htun K; Shamloo M; Mobley WC
    J Neurosci; 2012 Jul; 32(27):9217-27. PubMed ID: 22764230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
    Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome.
    Parrini M; Ghezzi D; Deidda G; Medrihan L; Castroflorio E; Alberti M; Baldelli P; Cancedda L; Contestabile A
    Sci Rep; 2017 Dec; 7(1):16825. PubMed ID: 29203796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome.
    de Souza FM; Busquet N; Blatner M; Maclean KN; Restrepo D
    Sci Rep; 2011; 1():137. PubMed ID: 22355654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
    Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
    Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse models of Down syndrome: gene content and consequences.
    Gupta M; Dhanasekaran AR; Gardiner KJ
    Mamm Genome; 2016 Dec; 27(11-12):538-555. PubMed ID: 27538963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein dynamics associated with failed and rescued learning in the Ts65Dn mouse model of Down syndrome.
    Ahmed MM; Dhanasekaran AR; Block A; Tong S; Costa AC; Stasko M; Gardiner KJ
    PLoS One; 2015; 10(3):e0119491. PubMed ID: 25793384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome.
    Fulton SL; Wenderski W; Lepack AE; Eagle AL; Fanutza T; Bastle RM; Ramakrishnan A; Hays EC; Neal A; Bendl J; Farrelly LA; Al-Kachak A; Lyu Y; Cetin B; Chan JC; Tran TN; Neve RL; Roper RJ; Brennand KJ; Roussos P; Schimenti JC; Friedman AK; Shen L; Blitzer RD; Robison AJ; Crabtree GR; Maze I
    Nat Commun; 2022 Oct; 13(1):6384. PubMed ID: 36289231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.
    Galdzicki Z; Siarey R; Pearce R; Stoll J; Rapoport SI
    Brain Res Brain Res Rev; 2001 Apr; 35(2):115-45. PubMed ID: 11336779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
    Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
    Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.